 The purpose of the study is to assess the safety and Pharmacokinetic PK profile of JNJ-56021927 and its active metabolite JNJ-56142060 after single-dose administration of 60 milligram mg, 120 mg, and 240 mg JNJ-56021927 as the tablet formulation in healthy male Japanese participants. 